| pubmed-article:17007710 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17007710 | lifeskim:mentions | umls-concept:C0264408 | lld:lifeskim |
| pubmed-article:17007710 | lifeskim:mentions | umls-concept:C0004048 | lld:lifeskim |
| pubmed-article:17007710 | lifeskim:mentions | umls-concept:C1518527 | lld:lifeskim |
| pubmed-article:17007710 | lifeskim:mentions | umls-concept:C0278329 | lld:lifeskim |
| pubmed-article:17007710 | lifeskim:mentions | umls-concept:C0239126 | lld:lifeskim |
| pubmed-article:17007710 | pubmed:issue | 531 | lld:pubmed |
| pubmed-article:17007710 | pubmed:dateCreated | 2006-9-29 | lld:pubmed |
| pubmed-article:17007710 | pubmed:abstractText | Inhaled corticosteroids are effective and safe treatments for childhood asthma in standard doses, yet at high dosages they may be associated with adverse events and suboptimal outcomes; add-on therapy is, therefore, recommended to minimise their use. We quantified prescribing of high-dose inhaled corticosteroids and add-on therapy in children in July 2003 and found that high-dose inhaled corticosteroids were prescribed to 10% of children aged 5-11 years and 6% of under-5's who were treated for asthma. Add-on therapy was lacking for almost half of these individuals. Some children were receiving treatment not in accord with current licences and evidence-based recommendations and, as such, may be at risk of adverse outcomes. | lld:pubmed |
| pubmed-article:17007710 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17007710 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17007710 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17007710 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17007710 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17007710 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17007710 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17007710 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17007710 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17007710 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17007710 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17007710 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17007710 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:17007710 | pubmed:issn | 0960-1643 | lld:pubmed |
| pubmed-article:17007710 | pubmed:author | pubmed-author:PriceDavidD | lld:pubmed |
| pubmed-article:17007710 | pubmed:author | pubmed-author:ThomasMikeM | lld:pubmed |
| pubmed-article:17007710 | pubmed:author | pubmed-author:TurnerSteveS | lld:pubmed |
| pubmed-article:17007710 | pubmed:author | pubmed-author:LeatherDaveD | lld:pubmed |
| pubmed-article:17007710 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17007710 | pubmed:volume | 56 | lld:pubmed |
| pubmed-article:17007710 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17007710 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17007710 | pubmed:pagination | 788-90 | lld:pubmed |
| pubmed-article:17007710 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
| pubmed-article:17007710 | pubmed:meshHeading | pubmed-meshheading:17007710... | lld:pubmed |
| pubmed-article:17007710 | pubmed:meshHeading | pubmed-meshheading:17007710... | lld:pubmed |
| pubmed-article:17007710 | pubmed:meshHeading | pubmed-meshheading:17007710... | lld:pubmed |
| pubmed-article:17007710 | pubmed:meshHeading | pubmed-meshheading:17007710... | lld:pubmed |
| pubmed-article:17007710 | pubmed:meshHeading | pubmed-meshheading:17007710... | lld:pubmed |
| pubmed-article:17007710 | pubmed:meshHeading | pubmed-meshheading:17007710... | lld:pubmed |
| pubmed-article:17007710 | pubmed:meshHeading | pubmed-meshheading:17007710... | lld:pubmed |
| pubmed-article:17007710 | pubmed:meshHeading | pubmed-meshheading:17007710... | lld:pubmed |
| pubmed-article:17007710 | pubmed:meshHeading | pubmed-meshheading:17007710... | lld:pubmed |
| pubmed-article:17007710 | pubmed:meshHeading | pubmed-meshheading:17007710... | lld:pubmed |
| pubmed-article:17007710 | pubmed:meshHeading | pubmed-meshheading:17007710... | lld:pubmed |
| pubmed-article:17007710 | pubmed:meshHeading | pubmed-meshheading:17007710... | lld:pubmed |
| pubmed-article:17007710 | pubmed:meshHeading | pubmed-meshheading:17007710... | lld:pubmed |
| pubmed-article:17007710 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:17007710 | pubmed:articleTitle | High-dose inhaled corticosteroid use in childhood asthma: an observational study of GP prescribing. | lld:pubmed |
| pubmed-article:17007710 | pubmed:affiliation | Department of General Practice and Primary Care, University of Aberdeen, Foresterhill Health Centre, Westburn Road, Aberdeen AB25 2AY. mikethomas@doctors.org.uk | lld:pubmed |
| pubmed-article:17007710 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17007710 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17007710 | lld:pubmed |
